Le Lézard
Classified in: Health, Business
Subjects: TNM, SCZ

$110 Million Credit Facility Announced for Affordable Assisted Living Care Facilities and Technology


PHOENIX and NEW YORK, Jan. 18, 2019 /PRNewswire-PRWeb/ -- Canexxia Equity Partners "Canexxia" or the "Company") today announced that, effective January 15, 2019, it entered into negotiations for a new credit facility, consisting of a $90 million term loan and a $30 million revolving line of credit. This new credit facility, once approved, will accelerate acquisitions of Assisted Living communities in Pittsburgh, PA and North East Ohio.

"This new credit facility will provide the momentum to follow through on our aggressive acquisition schedule" said Maceo Jourdan, the Company's Co-Founder and president. "Canexxia will consolidate a fragmented and aging sector that's frighteningly behind the times." The company expects to close the new credit facility within the next 20 days.

"The industry is ill-equipped to deal with the coming tsunami of aging Baby Boomers. This up-and-coming group expects a level of technology and service unreachable by existing communities," Mr. Jourdan adds, "With the advances in sensors, internet of things ("IoT"), and penetration of high-speed internet we can now deliver cutting-edge services the new aging population demands. Will will acquire communities through 2022 in order to meed the coming wave of demand."

About Canexxia Equity Partners
Canexxia delivers innovative technology to communities in the assisted living and home health care markets. The company specializes in acquisition and integration in healthcare. Our basic premise if fairly simple - to grow at a rapidly increasing rate into 2023 by vigorously acquiring single-owner and small-network assisted living communities. Canexxia concentrates on existing 3-4 star communities and plans to acquire between 2,000 and 5,000 beds in the United States of America. For more information, visit http://www.canexxia.com.

Forward Looking Statements

This press release and any attachments include "forward-looking statements," within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, in particular, statements about the Company's plans, strategies and prospects. The Company generally uses the words "may," "will," "could," "expect," "anticipate," "believe," "estimate," "plan," "intend" and similar expressions in this press release and any attachments to identify forward-looking statements. The Company bases these forward-looking statements on its current views with respect to future events and financial performance. Actual results could differ materially from those projected in the forward-looking statements.

 

SOURCE Cannexxia Equity Partners


These press releases may also interest you

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...



News published on and distributed by: